news on tirzepatide FDA approves new obesity drug from Eli Lilly named Zepbound Lilly CEO says weight-loss drug

Green Tea Polyphenol Epigallocatechin-3-Gallate and Cranberry Proanthocyanidins Act in Synergy with Cathelicidin (LL-37) to Reduce the LPS-Induced Inflammatory Response in a Three-Dimensional Co-Culture Model of Gingival Epithelial Cells and Fibroblasts

No one knows what causes the onset of Parkinsons disease, but environmental factors are thought to be a contributing factor

The European Association for the Study of Obesity has described obesity as the gateway to ill health, reflecting its strong association with a wide range of chronic conditions [2]

Earlier this year, a crackdown saw prescribers banned from dispensing weight loss jabs to patients who have just completed online questionnaires - like we did with Filson